HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An intron in the nuclear ribosomal DNA of Didymium iridis codes for a group I ribozyme and a novel ribozyme that cooperate in self-splicing.

Abstract
We have discovered a unique group I intron-like insertion (DiSSU) in the nuclear small subunit ribosomal RNA gene of the myxomycete Didymium iridis. By sequence, DiSSU consists of a group I ribozyme at the 5' end, an open reading frame (ORF) in the middle, and a novel element at the 3' end. Intron RNA self-splices in vitro to yield ten major processed RNAs, including a full-length circle. The group I ribozyme can efficiently cleave at an internal processing site, which separates the group I ribozyme from the ORF. Surprisingly, deletion that remove the entire group I ribozyme do not impair cleavage at the 3' splice site, implying that the 3' element itself is a catalytic RNA. Deletions that remove portions of the 3' element prevent utilization of the 5' splice site, suggesting that this element cooperates with the upstream group I ribozyme in splicing. DiSSU appears to be the first example for the cooperative interaction of distinct ribozymes in RNA splicing.
AuthorsS Johansen, V M Vogt
JournalCell (Cell) Vol. 76 Issue 4 Pg. 725-34 (Feb 25 1994) ISSN: 0092-8674 [Print] United States
PMID8124711 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • DNA Primers
  • DNA, Fungal
  • DNA, Ribosomal
  • RNA, Catalytic
Topics
  • Amino Acid Sequence
  • Base Sequence
  • DNA Primers (chemistry)
  • DNA, Fungal (genetics)
  • DNA, Ribosomal
  • Genes, Fungal
  • Hydrogen Bonding
  • Introns
  • Molecular Sequence Data
  • Myxomycetes (genetics)
  • Nucleic Acid Conformation
  • Open Reading Frames
  • RNA Splicing
  • RNA, Catalytic (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: